// App-Quantinova.ai

TCT-155 : The Interaction Between Clopidogrel and Calcium Channel Blockers on Platelet Reactivity and Long-Term Events after PCI

Researchers

Presenter

  • Giora Weisz

Principal Investigators

  • Ajay J. Kirtane

  • Ke Xu

  • Thomas Stuckey

  • Bernhard Witzenbichler

  • Michael Rinaldi

  • Franz-Josef Neumann

  • D. Christopher Metzger

  • Timothy D. Henry

  • David Cox

  • Peter L. Duffy

Medical Centers

  • Associate Professor of Medicine, UNC Chapel Hill, Charlotte, NC

  • The Ohio State University, Dublin, OH

  • Cardiovascular Research Foundation, Orangeburg, NY

  • Lehigh Valley Health Network, Allentown, PA

  • Columbia University Medical Center and the Cardiovascular Research Foundation, New York, NY

  • Cardiovascular Research Foundation, Orangeburg, NY

  • LeBauer CV Research Foundation, Greensboro, NC

  • Pinehurst Cardiology, Pinehurst, NC

  • Lebauer Cardiovascular Research Foundation, Greensboro, United States

  • Minneapolis Heart Institute Foundation at Abbott Northwestern Hospital, Minneapolis, MN

  • Charite Campus Benjamin Franklin, Berlin, Germany.

  • Mount Sinai Hospital, New York, NY

  • Columbia University Medical Center and the Cardiovascular Research Foundation, New York, NY

  • Wellmont Cancer Institute, Kingsport, TN

  • Columbia University / Cardiovascular Research Foundation, New York, NY

  • Universitaets-Herzzentrum Freiburg Bad Krozingen, Bad Krozingen, Germany

Locations

  • United States

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Acute Coronary Syndromes

  • Coronary Artery Disease

  • Dyslipidemia

  • Hypertension

  • Venous thrombosis

  • Diabetes

Biomarkers

  • N/A

Drug/Treatment

  • Clopidogrel bisulfate

  • Aspirin

  • Albyl-E

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved